Ravindra B Upasani

USPTO Granted Patents = 8 (Patent Applications = 15)

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 28(Granted Patents)

Company Filing History:

Sage Therapeutics, Inc.

Years Active: 2004-2024

Loading Chart...

8 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12129275 - Neuroactive steroids, compositions, and uses thereof (2024-10-29),

2. 11945785 - Pyrazine compounds as inhibitors of FLT3 (2024-04-02),

3. 10759828 - Neuroactive steroids, compositions, and uses thereof (2020-09-01),

4. 10435431 - 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof (2019-10-08),

5. 7576099 - Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same (2009-08-18),

6. 7432281 - Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same (2008-10-07),

7. 7115666 - Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain (2006-10-03),

8. 6835754 - Use of aryl nitrone compounds in methods for treating neuropathic pain (2004-12-28),

Title: The Innovations of Ravindra B Upasani

Introduction

Ravindra B Upasani is a notable inventor based in San Jose, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating central nervous system (CNS) conditions. With a total of eight patents to his name, Upasani's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents is a groundbreaking invention related to neuroactive steroids, which includes compositions and their uses. These compounds are designed to be effective in preventing and treating various CNS-related conditions in mammals. Another significant patent involves pyrazine compounds that act as inhibitors of FLT3, a critical target in the treatment of proliferative diseases, including hematological malignancies. These inventions highlight Upasani's commitment to advancing therapeutic options in the medical field.

Career Highlights

Throughout his career, Upasani has worked with prominent companies such as Renovis, Inc. and Sage Therapeutics, Inc. His experience in these organizations has allowed him to collaborate on innovative projects that push the boundaries of pharmaceutical research.

Collaborations

Some of his notable coworkers include Boyd Lynn Harrison and Benny C Askew. Their collective expertise has contributed to the success of various projects and patents in which Upasani has been involved.

Conclusion

Ravindra B Upasani's contributions to the field of pharmaceuticals through his patents and collaborations demonstrate his dedication to innovation and improving healthcare solutions. His work continues to influence the development of new treatments for CNS-related conditions.

This text is generated by artificial intelligence and may not be accurate.